European Stock Market News: Major Indices Show Divergent Movements

SelfCustodyIssues · 2026-02-12T15:08:21+00:00

The European news market shows a mixed investment environment with the UK and France experiencing strong stock market gains while Germany faces selling pressure. The UK’s FTSE 100 and France’s CAC indices reached record highs, while Germany's DAX fell, notably affected by declines in healthcare stocks.

SelfCustodyIssues

2026-02-12 15:08:21

Abstract generation in progress

In the European news market, major regional stock indices showed mixed performance. While the UK and France experienced strong gains, the German market faced selling pressure, reflecting a complex overall investment environment across Europe.

UK and France: Steady Rises Reach Record Highs

The UK’s FTSE 100 index traded at record-high levels throughout the session, peaking at 10,481 points before closing at 10,402 points, up 87 points (0.85%). France’s CAC index also rose by 1%, closing at 8,262 points with an increase of 82 points, reaching a high not seen in about three weeks. These upward trends suggest continued buying interest among market participants and indicate solid demand for stocks in Western Europe.

Germany Market and Sector Trends: Clear Divergence

Meanwhile, Germany’s DAX index declined for the second consecutive day, ending trading at 24,603 points, down 177 points (0.72%). While telecommunications and consumer-related stocks showed relative strength, banking and healthcare stocks faced selling pressure.

Among these, Denmark’s major pharmaceutical company Novo Nordisk drew significant attention. The company experienced a sharp 17% drop, losing approximately $50 billion in market capitalization. This decline was primarily driven by the company’s announcement of full-year sales and profit outlook reductions. This news exerted selling pressure across healthcare-related stocks and influenced overall market movements in Europe.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.